GAPP is a Genome Canada funding program for Receptors (such as industry, government, not-for-profit, other organizations) working with an academic partner to validate an ‘omics-driven technology.

Expressions of Interest are due to Ontario Genomics on May 15th.

OBIO Member, Focal Healthcare Inc, has been granted a Class II Health Canada Medical Device License for its targeted prostate biopsy device, Fusion Bx

OBIO CAAP 2016 company, Swift Medical, a market leader in machine vision and machine learning platforms for mobile health and data analytics, today announced completing a rounds of funding led by Montreal's Real Ventures with participation from Relay Ventures, Lumira Capital, MaRS IAF and a strategic partner.

MaRS Innovation (MI) and its South Korean partner, Korea Health Industry Development Institute (KHIDI), continue to build on the five-year global partnership agreement signed in December 2016 during Premier Wynne’s mission to the Republic of Korea.

OBIO CAAP 2014 company, Intronix Technologies, will be launching their "Myoguide DOC" 

OBIO Member company, Steadiwear, wins again!

Former OBIO CAAP companies, Eve Medical and QoC Health, have been quoted in The Globe and Mail this week

OBIO Member, the Centre for the Commercialization of Antibodies and Biologics (CCAB)has signed an Agreement with Pionyr Immunotherapeutics Inc.

OBIO Member, Steadiwear, has won 1st Place in the RESI on MaRS Innovation Challenge.  

OBIO CAAP companies, Pathcore and WinterLight Labs have both been announced as recipients of the Ontario Health Technology Fund!

Hamilton Health Sciences and IBM are seeking proposals for exciting, innovative new projects aimed at improving the delivery of health care.  

OBIO Pre-CAAP company, MedStack, has turned 2!

OBIO CAAP 2016 company, QoC Health, with SMArTVIEW has been selected for one of 15 Ontario Health Technology Grants (HTF).

Former OBIO CAAP company, has announced the launch of Canada’s first HPV at home screening service

CellAegis Devices has announced $9.5 Million US financing to support clinical and regulatory advancement of their autoRIC® Device.

Conavi Medical, has announced Health Canada approval of their Foresight Intracardiac Echocardiography (ICE) System™.

OBIO is excited to welcome MedStack as part of OBIO's Member Benefit Package!

Former OBIO CAAP company Syng Pharmaceuticals, will be attending the BIOCOM Global Pharma Partnering Conference this week

MedStack Inc., the Platform for App-Enabled Healthcare, announced at the 2017 HIMSS Annual Conference & Exhibition that its integrated native FHIR database API is now employed by healthcare app companies

QoC Health are hiring for 3 positions: Senior Android Developer, Senior Front End Developer, Senior iOS Developer